MENU

PolyPid (PYPD) Ownership - Who owns PolyPid?

Profile

Industry
N/A
Address
18 Hasivim Street
Phone
+972 747195700
Employees
62
Web
https://www.polypid.com

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
16.5M
P/E Ratio
N/A
Total Cash
9.35M
Projected Growth
N/A
Total Debt
11.03M
Revenue
N/A
Risk (Beta)
1.50
Dividend Yield
N/A
Total Cash/Share
1.95
Total Debt/Equity
N/A
Revenue/Share
null USD as % of share price

Fundamentals

PYPD
Capitalization
16.5M
P/E Ratio
N/A
Risk (Beta)
1.50
Dividend Yield
N/A
Total Cash
9.35M
Total Cash/Share
1.95
Total Debt
11M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0%
Revenue
0
ROE
N/A
Book Value
1.6M
P/B Ratio
10.31
Cash Flow
N/A
Earnings
-8.76
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
0
Current Ratio
0.95
Current Revenue Per Employee
N/A
Dividends Per Share - Security
N/A
EBITDA
-21.26M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-107.89
Shares Held By Institutions
5.22M
Shares Outstanding - Current
4.8M
Total Liabilities
17.9M
Total Volume MTD
N/A
Value
-1
Gain YTD
-9.474
View a ticker or compare two or three
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

a clinical stage biopharmaceutical company focusing on the development, manufacture, and commercialization of administered therapies to improve surgical outcomes

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
18 Hasivim Street
Phone
+972 747195700
Employees
62
Web
https://www.polypid.com